Research Site
Seoul, South Korea
18,727 recruiting
Showing 1–20 of 370 trials
Recruiting
Phase 4
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
Chronic Obstructive Pulmonary DiseaseHyperinflation
AstraZeneca56 enrolled7 locationsNCT07073950
Recruiting
Anifrolumab Pregnancy Study
Systemic Lupus Erythematosus
AstraZeneca500 enrolled1 locationNCT07049653
Recruiting
Phase 3
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Eosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilia Syndrome (HES)
AstraZeneca14 enrolled15 locationsNCT06512883
Recruiting
QUARTZ: Comparative Effectiveness of Switching From Albuterol to Albuterol/Budesonide Versus Adding Low-dose ICS or LTRA to Albuterol
Asthma
AstraZeneca8,000 enrolledNCT07787117
Recruiting
A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
Severe Eosinophilic Asthma
AstraZeneca335 enrolled28 locationsNCT07214753
Recruiting
Phase 3
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prostate Cancer
AstraZeneca700 enrolled342 locationsNCT06952803
Recruiting
Phase 1
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Rheumatoid ArthritisSystemic Lupus Erythematosus
AstraZeneca48 enrolled34 locationsNCT07201558
Recruiting
Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
AstraZeneca1,160 enrolled312 locationsNCT06692738
Recruiting
Phase 1
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
Healthy Participants
AstraZeneca50 enrolled2 locationsNCT07013643
Recruiting
Phase 4
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
Systemic Lupus Erythematosus
AstraZeneca16 enrolled1 locationNCT06594068
Recruiting
Anifrolumab Malignancy and Serious Infections Study
Systemic Lupus Erythematosus
AstraZeneca3,506 enrolled4 locationsNCT07000110
Recruiting
Phase 2
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
Bronchiectasis With Pseudomonas Aeruginosa Colonization
AstraZeneca435 enrolled185 locationsNCT07088926
Recruiting
ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia
AsthmaChronic Rhinosinusitis With Nasal Polyps (CRSwNP)
AstraZeneca110 enrolled11 locationsNCT07399665
Recruiting
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis
Myasthenia Gravis, Generalized
AstraZeneca50 enrolled12 locationsNCT06909253
Recruiting
Observational Study of Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults
Dilated Cardiomyopathy
AstraZeneca10 enrolledNCT07646600
Recruiting
Phase 2
Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
IgAN
Sitala Bio LTD15 enrolledNCT07606352
Recruiting
Phase 1
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
Healthy Participants
AstraZeneca152 enrolledNCT07723833
Recruiting
Phase 1
Study of Safety and PK of AZD0543 in Healthy Adults
Human Metapneumovirus Infection
AstraZeneca144 enrolledNCT07824622
Recruiting
Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
AstraZeneca11,300 enrolled953 locationsNCT06677060
Recruiting
Ravulizumab Outcomes in Polish Patients With aHUS
Atypical Hemolytic Uremic Syndrome
AstraZeneca80 enrolled10 locationsNCT07399730